Denali Therapeutics Inc. DNLI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $406.4M-3.0% | $418.78M-0.4% | $420.66M+0.9% | $416.95M+2.8% | $405.65M+2.3% | ||
| $140.72M+3.0% | $136.56M+7.4% | $127.16M+9.0% | $116.63M+6.5% | $109.56M+3.9% | ||
| $547.12M-1.5% | $555.34M+1.4% | $547.82M+2.7% | $533.58M+3.6% | $515.21M+2.7% | ||
| -$547.12M+1.5% | -$555.34M-1.4% | -$547.82M-2.7% | -$533.58M-3.6% | -$515.21M-5.7% | ||
| -$508.02M+0.9% | -$512.54M-2.8% | -$498.74M-4.1% | -$479.03M-5.5% | -$453.94M-7.4% | ||
| -$2.88+3.0% | -$2.97-1.7% | -$2.92-3.9% | -$2.81-4.9% | -$2.68-3.9% | ||
| -$535.42M+1.6% | -$544.16M-1.2% | -$537.65M-2.5% | -$524.52M-3.4% | -$507.25M-5.8% | ||
| -$547.12M+1.5% | -$555.34M-1.4% | -$547.82M-2.7% | -$533.58M-3.6% | -$515.21M-5.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Denali Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Denali Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.